Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
4.30
+0.04 (1.06%)
Bozor ochiq: Aug 12, 2026, 3:15 PM EDT
4.25
0.00 (0.00%)
Oldingi bozordan keyin: Aug 11, 2026, 4:10 PM EDT
Oramed Pharmaceuticals Inc. dorilar uchun tadqiqot va ishlanmalar bilan shug'ullanadi, terapevtik oqsillarni og'iz orqali yuborish uchun texnologik platformaga ega. Kompaniya ORMD-0801ni ishlab chiqmoqda, bu insulin kapsulasi bo'lib, u diabetga chalingan bemorlarni davolash uchun III fazali klinik sinovlardan o'tmoqda. Kompaniya COVID-19 uchun og'iz orqali yuboriladigan vaktsinalarni tijoratlashtirish bo'yicha Oravax Medical Inc. bilan litsenziya shartnomalariga ega. Oramed Pharmaceuticals Inc. 2002 yilda tashkil etilgan va uning bosh qarorgohi Nyu-York, Nyu-Yorkda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Miriam Kidron Ph.D. | Chief Scientific Officer & Director |
| Mr. Avraham Gabay | CFO, Treasurer & Secretary |
| Mr. Joshua Hexter | Chief Operating & Business Officer |
| Mr. Nadav Kidron Esq. | President, CEO & Executive Chairman |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-08-03 | DEF 14A | ea0297466-01.htm |
| 2026-06-30 | 8-K | ea0296520-8k_oramed.htm |
| 2026-05-19 | 10-Q | ea0290983-10q_oramed.htm |
| 2026-05-15 | NT 10-Q | ea029019601-nt10q_oramed.htm |
| 2026-03-31 | 8-K | ea0284244-8k_oramed.htm |
| 2026-03-26 | 10-K | ea0282618-10k_oramed.htm |
| 2026-02-20 | 8-K | ormp-20260219.htm |
| 2026-01-14 | 8-K | ea0272889-8k_oramed.htm |
| 2026-01-07 | 8-K | ea0271929-8k_oramed.htm |
| 2025-12-31 | 8-K | ormp-20251230.htm |